Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "Telangana"

132 News Found

Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke
Hospitals | October 29, 2021

Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke

It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology


KIMS Hospitals to acquire 51.07 % stake in Sunshine Hospitals
Hospitals | October 28, 2021

KIMS Hospitals to acquire 51.07 % stake in Sunshine Hospitals

The combined entity will have 12 hospitals with 3,666 beds


Pharmexcil exhibition and conference on Sept 21-22
Events | September 18, 2021

Pharmexcil exhibition and conference on Sept 21-22

The event will include an exhibition and sector-wise sessions for two days with participation by officials from the Ministry of Commerce, export promotion councils and members of the industry


ICMR to use drones for vaccine delivery
Supply Chain | September 14, 2021

ICMR to use drones for vaccine delivery

ICMR receives conditional exemption from Drone Rules 2021 to speed up vaccine delivery in the A&N Islands, Manipur and Nagaland


Shilpa Medicare receives approval for 2-Deoxy-2-Glucose powder
News | September 01, 2021

Shilpa Medicare receives approval for 2-Deoxy-2-Glucose powder

The powder is approved for the treatment of adjunct therapy in moderate to severe Covid-19 patients


CRISIL positive on Krishna Institute of Medical Sciences
News | August 25, 2021

CRISIL positive on Krishna Institute of Medical Sciences

CRISIL Ratings has revised its outlook on the long term ratings of Krishna Institute Of Medical Sciences Limited (KIMS) to 'Positive' from 'Stable' while reaffirming the ratings at 'CRISIL AA-/CRISIL A1+'


We plan to invest Rs. 1,000 Cr in the next 3 to 4 years : Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals
interviews | August 07, 2021

We plan to invest Rs. 1,000 Cr in the next 3 to 4 years : Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals

India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.


'We plan to invest Rs. 1,000 Cr in the next 3 to 4 years.' Priyanka Chigurupati, Executive Director, Granules Pharmaceutical Inc.
Interviews | June 10, 2021

'We plan to invest Rs. 1,000 Cr in the next 3 to 4 years.' Priyanka Chigurupati, Executive Director, Granules Pharmaceutical Inc.

In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:


Shilpa Medicare Jadcherla facility gets GMP certification from Russia
Policy | May 29, 2021

Shilpa Medicare Jadcherla facility gets GMP certification from Russia

The GMP certificate is valid for three years until April 2024.


DCGI approves anti-COVID drug developed by DRDO
Policy | May 10, 2021

DCGI approves anti-COVID drug developed by DRDO

The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production